These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 9840917)

  • 1. Inhibition of Fas-induced apoptosis by Bcl-2.
    Kawahara A; Kobayashi T; Nagata S
    Oncogene; 1998 Nov; 17(20):2549-54. PubMed ID: 9840917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Helenalin triggers a CD95 death receptor-independent apoptosis that is not affected by overexpression of Bcl-x(L) or Bcl-2.
    Dirsch VM; Stuppner H; Vollmar AM
    Cancer Res; 2001 Aug; 61(15):5817-23. PubMed ID: 11479221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intracellular mechanisms of TRAIL: apoptosis through mitochondrial-dependent and -independent pathways.
    Suliman A; Lam A; Datta R; Srivastava RK
    Oncogene; 2001 Apr; 20(17):2122-33. PubMed ID: 11360196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apoptosis induced by DNA damage O6-methylguanine is Bcl-2 and caspase-9/3 regulated and Fas/caspase-8 independent.
    Ochs K; Kaina B
    Cancer Res; 2000 Oct; 60(20):5815-24. PubMed ID: 11059778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The recruitment of Fas-associated death domain/caspase-8 in Ras-induced apoptosis.
    Chen CY; Juo P; Liou JS; Li CQ; Yu Q; Blenis J; Faller DV
    Cell Growth Differ; 2001 Jun; 12(6):297-306. PubMed ID: 11432804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ligation of CD40 potentiates Fas-mediated activation of the cysteine protease CPP32, cleavage of its death substrate PARP, and apoptosis in Ramos-Burkitt lymphoma B cells.
    An S; Yap D; Knox KA
    Cell Immunol; 1997 Nov; 181(2):139-52. PubMed ID: 9398401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apoptosis induced by a chimeric Fas/FLICE receptor: lack of requirement for Fas- or FADD-binding proteins.
    Memon SA; Hou J; Moreno MB; Zacharchuk CM
    J Immunol; 1998 Mar; 160(5):2046-9. PubMed ID: 9498739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apoptosis signaling pathways in normal T cells: differential activity of Bcl-2 and IL-1beta-converting enzyme family protease inhibitors on glucocorticoid- and Fas-mediated cytotoxicity.
    Moreno MB; Memon SA; Zacharchuk CM
    J Immunol; 1996 Nov; 157(9):3845-9. PubMed ID: 8892614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential role of caspase-8 and BID activation during radiation- and CD95-induced apoptosis.
    Belka C; Rudner J; Wesselborg S; Stepczynska A; Marini P; Lepple-Wienhues A; Faltin H; Bamberg M; Budach W; Schulze-Osthoff K
    Oncogene; 2000 Feb; 19(9):1181-90. PubMed ID: 10713706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fas-mediated apoptosis in neuroblastoma requires mitochondrial activation and is inhibited by FLICE inhibitor protein and Bcl-2.
    Poulaki V; Mitsiades N; Romero ME; Tsokos M
    Cancer Res; 2001 Jun; 61(12):4864-72. PubMed ID: 11406564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Crm-A, bcl-2 and NDGA inhibit CD95L-induced apoptosis of malignant glioma cells at the level of caspase 8 processing.
    Wagenknecht B; Schulz JB; Gulbins E; Weller M
    Cell Death Differ; 1998 Oct; 5(10):894-900. PubMed ID: 10203695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Signaling events triggered by tumor necrosis factor-related apoptosis-inducing ligand (TRAIL): caspase-8 is required for TRAIL-induced apoptosis.
    Seol DW; Li J; Seol MH; Park SY; Talanian RV; Billiar TR
    Cancer Res; 2001 Feb; 61(3):1138-43. PubMed ID: 11221844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic inhibitors sensitize for CD95 (APO-1/Fas)-induced apoptosis by down-regulating Fas-associated death domain-like interleukin 1-converting enzyme inhibitory protein expression.
    Fulda S; Meyer E; Debatin KM
    Cancer Res; 2000 Jul; 60(14):3947-56. PubMed ID: 10919673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of differential overexpression of Bcl-2 on apoptosis, proliferation, and telomerase activity in Jurkat T cells.
    Johnson VL; Cooper IR; Jenkins JR; Chow SC
    Exp Cell Res; 1999 Aug; 251(1):175-84. PubMed ID: 10438583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FADD deficiency sensitises Jurkat T cells to TNF-alpha-dependent necrosis during activation-induced cell death.
    Lawrence CP; Chow SC
    FEBS Lett; 2005 Nov; 579(28):6465-72. PubMed ID: 16289096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of apoptosis in 9-nitrocamptothecin-treated DU145 human prostate carcinoma cells correlates with de novo synthesis of CD95 and CD95 ligand and down-regulation of c-FLIP(short).
    Chatterjee D; Schmitz I; Krueger A; Yeung K; Kirchhoff S; Krammer PH; Peter ME; Wyche JH; Pantazis P
    Cancer Res; 2001 Oct; 61(19):7148-54. PubMed ID: 11585748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Caspase-8/FLICE functions as an executioner caspase in anticancer drug-induced apoptosis.
    Engels IH; Stepczynska A; Stroh C; Lauber K; Berg C; Schwenzer R; Wajant H; Jänicke RU; Porter AG; Belka C; Gregor M; Schulze-Osthoff K; Wesselborg S
    Oncogene; 2000 Sep; 19(40):4563-73. PubMed ID: 11030145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell type specific involvement of death receptor and mitochondrial pathways in drug-induced apoptosis.
    Fulda S; Meyer E; Friesen C; Susin SA; Kroemer G; Debatin KM
    Oncogene; 2001 Mar; 20(9):1063-75. PubMed ID: 11314043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential regulation of Fas-mediated apoptosis of rheumatoid synoviocytes by tumor necrosis factor alpha and basic fibroblast growth factor is associated with the expression of apoptosis-related molecules.
    Kobayashi T; Okamoto K; Kobata T; Hasunuma T; Kato T; Hamada H; Nishioka K
    Arthritis Rheum; 2000 May; 43(5):1106-14. PubMed ID: 10817565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thyroid carcinoma cells are resistant to FAS-mediated apoptosis but sensitive to tumor necrosis factor-related apoptosis-inducing ligand.
    Mitsiades N; Poulaki V; Tseleni-Balafouta S; Koutras DA; Stamenkovic I
    Cancer Res; 2000 Aug; 60(15):4122-9. PubMed ID: 10945619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.